AppLovin Shares Rally Past Key Technical Level Following Bullish Analyst Outlook South Koreas Deputy Prime Minister Calls for AI Wealth to Benefit Public Amid Samsung Labor Disputes Silver Consolidates as Market Eyes Potential Breakout Toward 8125 Gold Price Focuses on 4500 Support Level Amid Renewed USIran Uncertainty Oil Price Reversal Highlights Geopolitical Risk as Key Driver for Crude Markets Consumer Credit Growth Surges in December Signaling Robust Consumer Spending TFSL Q1 2026 Earnings EPS Misses Estimates Slightly Amid Steady Operating Performance PAYS Q1 2026 Earnings Earnings Beat Estimates as EPS Surprises to the Upside MLI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Deutsche Bank DB Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Market Reaction ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Bonk Inc BNKK Slides 556 as Bearish Pressure Intensifies Near Key Support AutoZone AZO Slips Modestly Testing Key Technical Levels Amid Mixed Sentiment Crescent Capital BDC CCAP Edges Lower Amid Modest ProfitTaking Hercules Capital Notes HCXY Edge Higher Yield and Stability in Focus J W Mays Inc MAYS Holds Steady at 414 as RangeBound Trading Persists Beyond Acquires Buy Buy Baby Brand Rights to Reunite with Bed Bath Beyond GREEL Q1 2025 Earnings Narrower Loss Surpasses Estimates as Senior Notes Remain Stable AbCellera Biologics ABCL Surges 53 as Biotech Sentiment Improves CHD Q1 2026 Earnings EPS Beat Fails to Lift Stock Amid Mixed Signals Nable Inc NABL Q1 2026 Earnings EPS Misses Estimates Despite Narrow Gap Stock Gains 28 LCID Q1 2026 Earnings WiderThanExpected Loss Highlights Persistent Cash Burn DNN Q1 2026 Earnings Widerthanexpected loss as uranium development costs mount QuinStreet Q1 2026 Earnings EPS Miss But Stock Pushes Higher Jaguar Health Inc Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges XCUR Q2 2022 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue